Jul 18, 2024 15:34 JST

Source: NEC Corporation

VitalLife and Bumrungrad International Hospital in Thailand Launch NEC's FonesVisuas Test: First Major Deployment Outside Japan, Revolutionizing Disease Risk Prediction

Bangkok, Thailand, and Tokyo, Japan, July 18, 2024 - (JCN Newswire) - VitalLife Scientific Wellness Center, a subsidiary of Bumrungrad International Hospital in Bangkok, Thailand, recognized as one of Newsweek's World's Best Hospitals for four consecutive years (2021-2024), and NEC Corporation (NEC; TSE: 6701), a leader in IT, network and AI technologies, have announced the introduction of NEC's FonesVisuas Test in Thailand. This innovative blood test, previously exclusive to Japan, now marks its international debut in the VitalLife Scientific Wellness Center.

VitalLife Scientific Wellness Center, a subsidiary of Bumrungrad International Hospital

According to the World Health Organization (WHO), the global rise in lifestyle-related diseases and dementia underscores the urgency for advanced predictive diagnostics (*1). Concurrently, OECD iLibrary data has identified cancer and cardiovascular diseases as leading causes of mortality worldwide (*2), amplifying the urgency for proactive health management solutions.

For over two decades, VitalLife has pioneered personalized healthcare solutions by integrating cutting-edge research and technology. The addition of the FonesVisuas Test represents a significant advancement by analyzing daily-changing proteins. From just a small blood sample, the test can predict risks associated with conditions such as dementia, heart attack, lung cancer, and chronic kidney disease over the next few years.

This initiative complements VitalLife's existing genetic testing services at Bumrungrad International Hospital, reinforcing its commitment to enhancing patient outcomes through tailored health interventions. By providing personalized lifestyle recommendations, VitalLife aims to mitigate disease risks and improve overall community health.

Going forward, NEC plans to expand provision of the FonesVisuas Test internationally, particularly in the APAC region, underscoring its commitment to advancing global healthcare standards.

(1) www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases, https://www.who.int/news-room/fact-sheets/detail/dementia
(2) www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2023_7a7afb35-en

About Bumrungrad International Hospital

Bumrungrad International Hospital, founded in 1980, is a globally recognized multi-specialty hospital located in Bangkok, Thailand. It has been listed on the Stock Exchange of Thailand since 1989 and is one of the largest private hospitals in Southeast Asia, treating over 1.1 million patients from more than 190 countries annually.The hospital boasts numerous state-of-the-art facilities, including a fully licensed medical heliport, automated laboratories, and specialized centers such as the Heart Institute and the Horizon Cancer Center. It offers comprehensive inpatient and outpatient services, including 580 inpatient beds and 275 examination suites, and features advanced medical technologies like the MAKO Robot for knee replacements and the da Vinci Surgical System for robotic-assisted surgeries.Bumrungrad is notable for its high standards of quality and safety, being the first hospital in Asia to receive Joint Commission International (JCI) accreditation in 2002 and consistently earning re-accreditation. It also achieved the Global Healthcare Accreditation with Excellence.The hospital provides a wide range of medical services, from general check-ups to complex surgeries, supported by an international team of over 1,200 physicians and 900 nurses. Additionally, it offers amenities such as a Sky Lobby, various dining options, and hospital-wide Wi-Fi to ensure a comfortable patient experience.For more detailed information, you can visit their official website: https://www.bumrungrad.com

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.

Media contact:
7-1, Shiba 5-chome,
Minato-ku, Tokyo 108-8001, Japan
Phone: +81-3-3454-1111

Source: NEC Corporation
Sectors: MedTech

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


NEC Receives Telecom Review's Global Excellence Award for Innovative Telecom B2B/ Enterprise Network Solutions
December 18 2024 16:12 JST
 
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024
December 12 2024 15:27 JST
 
NEC begins sale of 100G QSFP28 ZR4 single-fiber bi-directional optical transceiver
December 09 2024 13:06 JST
 
JAL and NEC Test AI-Powered Carry-On Baggage Analysis Solution
November 29 2024 14:27 JST
 
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
November 20 2024 14:30 JST
 
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
November 18 2024 16:29 JST
 
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program
November 13 2024 11:05 JST
 
NEC receives order for next-generation supercomputer system from Japan's National Institutes for Quantum Science and Technology and National Institute for Fusion Science
November 13 2024 10:16 JST
 
NEC participates in COP29 climate change conference
November 12 2024 18:25 JST
 
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
November 08 2024 09:31 JST
 
More Press release >>

Latest Press Release


More Latest Release >>